Finance & Economy
-

NASH Group to Showcase Industry 4.0 solutions at Automation Expo 2026
National: NASH, an engineering-led technology and manufacturing company, will showcase its latest intelligent industrial solutions at Automation Expo 2026, to be held from July 22–25 at the Bombay Exhibition Centre, Mumbai. The company will demonstrate…
-

Gold and Silver under pressure as Oil Shock Revives Inflation Fears
Precious metals had a tough week. Gold futures slipped a little over 2%, and spot gold lost around 3%. Silver fared far worse — spot silver sank nearly 8%, and Comex silver futures dropped close…
-

Meghna Infracon Infrastructure Limited Launches 2.8 Lakh Sq. Ft. ‘Meghna One’, a ₹300 Crore GDV, 17-Storey Biophilic Commercial Tower in Thane’s Wagle Estate, Home to 1,000+ Businesses
Thane’s first lake-facing biophilic commercial address offers flexible office spaces from 569 sq. ft. to 10,500 sq ft on single floor., bringing together Grade-A workspaces, wellness, retail and hospitality within one integrated commercial ecosystem Mumbai,…
-

GlobalPay Launches GlobalPay Connect, a Forex Card Distribution Platform to Expand India’s Forex Distribution Ecosystem
The new partnership platform enables RBI-licensed institutions to become Authorized GlobalPay Forex Card Distributors, unlocking new business opportunities through secure, multi-currency forex card solutions. Mumbai: WSFx Global Pay Ltd (GlobalPay) (BSE: 511147), the trusted standard…
-

Belrise Industries’ recent qualified institutional placement (QIP).
Belrise has successfully completed its QIP, raising Rs. 1,700 crore. On the back of strong investor interest, Belrise upsized its QIP by ~40%, from the Rs. 1,200 crore base issue to Rs. 1,700 crore. The…
-

Takeda’s QDENGA (TAK-003) becomes the first dengue vaccine to be approved in India, marking a new era in dengue prevention
New Delhi: Takeda Biopharmaceuticals India Pvt. Ltd. today announced that the Drug Controller General of India (DCGI) has granted market authorization (CT-20, New Drugs and Clinical Trials (NDCT) Rules, 2019) for QDENGA, Takeda’s dengue vaccine…





